Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giacomina Loriga

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Recent Patents on Cardiovascular Drug Discovery|May 5, 2010
Direct Renin inhibition: promising treatment in renoprotection?Giacomina Loriga
Amino Acids|January 27, 2012
Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapyAngelo Zinellu, Salvatore Sotgia, Giacomina Loriga, et al.
Nephron. Clinical Practice|November 1, 2008
Renal hemodynamics and renoprotectionGiacomina Loriga, Gianpaolo Vidili, Piero Ruggenenti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 5, 2012
LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapyAngelo Zinellu, Salvatore Sotgia, Elisabetta Pisanu, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[LDL-apheresis in patients with familial autosomal recessive hypercholesterolemia]Piergiorgio Pala, Giacomina Loriga, Antonio Carassino, et al.
Hypertension (Dallas, Tex. : 1979)|July 22, 2009
Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapyPiero Ruggenenti, Dario Cattaneo, Giacomina Loriga, et al.
American Journal of Nephrology|August 18, 2010
Increased low-density lipoprotein S-homocysteinylation in chronic kidney diseaseAngelo Zinellu, Giacomina Loriga, Bastianina Scanu, et al.
Lancet (London, England)|March 16, 2005
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trialPiero Ruggenenti, Annalisa Perna, Giacomina Loriga, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trialPiero Ruggenenti, Annalisa Perna, Marcello Tonelli, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Recent Patents on Cardiovascular Drug Discovery|May 5, 2010
Direct Renin inhibition: promising treatment in renoprotection?Giacomina Loriga
Amino Acids|January 27, 2012
Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapyAngelo Zinellu, Salvatore Sotgia, Giacomina Loriga, et al.
Nephron. Clinical Practice|November 1, 2008
Renal hemodynamics and renoprotectionGiacomina Loriga, Gianpaolo Vidili, Piero Ruggenenti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 5, 2012
LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapyAngelo Zinellu, Salvatore Sotgia, Elisabetta Pisanu, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[LDL-apheresis in patients with familial autosomal recessive hypercholesterolemia]Piergiorgio Pala, Giacomina Loriga, Antonio Carassino, et al.
Hypertension (Dallas, Tex. : 1979)|July 22, 2009
Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapyPiero Ruggenenti, Dario Cattaneo, Giacomina Loriga, et al.
American Journal of Nephrology|August 18, 2010
Increased low-density lipoprotein S-homocysteinylation in chronic kidney diseaseAngelo Zinellu, Giacomina Loriga, Bastianina Scanu, et al.
Lancet (London, England)|March 16, 2005
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trialPiero Ruggenenti, Annalisa Perna, Giacomina Loriga, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trialPiero Ruggenenti, Annalisa Perna, Marcello Tonelli, et al.
Pageof 1